National Health Investors (NYSE:NHI) Price Target Increased to $65.00 by Analysts at Truist Financial

National Health Investors (NYSE:NHI) had its price objective boosted by Truist Financial from $58.00 to $65.00 in a research note released on Wednesday morning, Benzinga reports. The brokerage currently has a hold rating on the real estate investment trust’s stock.

Several other equities analysts have also commented on NHI. Wells Fargo & Company upped their price target on shares of National Health Investors from $63.00 to $69.00 and gave the stock an overweight rating in a research report on Thursday, May 30th. Wedbush upped their price target on shares of National Health Investors from $64.00 to $66.00 and gave the stock an outperform rating in a research report on Monday, March 18th. BMO Capital Markets upgraded shares of National Health Investors from a market perform rating to an outperform rating and set a $67.00 price target for the company in a research report on Tuesday, March 12th. Finally, StockNews.com lowered shares of National Health Investors from a buy rating to a hold rating in a research report on Thursday, April 18th. Five investment analysts have rated the stock with a hold rating and four have issued a buy rating to the company’s stock. Based on data from MarketBeat, the company currently has a consensus rating of Hold and an average target price of $62.13.

National Health Investors Price Performance

Shares of NYSE NHI opened at $66.89 on Wednesday. National Health Investors has a 1-year low of $48.51 and a 1-year high of $68.14. The firm has a market capitalization of $2.90 billion, a PE ratio of 21.93 and a beta of 1.00. The company has a debt-to-equity ratio of 0.91, a current ratio of 13.24 and a quick ratio of 13.24. The business’s fifty day moving average price is $65.22 and its two-hundred day moving average price is $59.83.

National Health Investors Announces Dividend

The business also recently announced a quarterly dividend, which will be paid on Friday, August 2nd. Investors of record on Friday, June 28th will be given a $0.90 dividend. The ex-dividend date of this dividend is Friday, June 28th. This represents a $3.60 dividend on an annualized basis and a yield of 5.38%. National Health Investors’s dividend payout ratio is presently 118.03%.

Insider Activity at National Health Investors

In other National Health Investors news, Director Robert A. Mccabe, Jr. purchased 437 shares of the business’s stock in a transaction on Friday, May 31st. The stock was bought at an average cost of $65.83 per share, with a total value of $28,767.71. Following the acquisition, the director now owns 21,585 shares of the company’s stock, valued at $1,420,940.55. The acquisition was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink. 8.21% of the stock is currently owned by insiders.

Institutional Investors Weigh In On National Health Investors

Institutional investors and hedge funds have recently bought and sold shares of the business. International Assets Investment Management LLC lifted its holdings in National Health Investors by 3,690.7% in the 4th quarter. International Assets Investment Management LLC now owns 28,430 shares of the real estate investment trust’s stock valued at $1,588,000 after acquiring an additional 27,680 shares during the last quarter. Land & Buildings Investment Management LLC lifted its stake in National Health Investors by 81.8% during the fourth quarter. Land & Buildings Investment Management LLC now owns 412,052 shares of the real estate investment trust’s stock valued at $23,013,000 after buying an additional 185,377 shares in the last quarter. Principal Financial Group Inc. lifted its stake in National Health Investors by 8.5% during the fourth quarter. Principal Financial Group Inc. now owns 1,870,632 shares of the real estate investment trust’s stock valued at $104,475,000 after buying an additional 146,735 shares in the last quarter. Mirae Asset Global Investments Co. Ltd. lifted its stake in National Health Investors by 4.6% during the fourth quarter. Mirae Asset Global Investments Co. Ltd. now owns 189,221 shares of the real estate investment trust’s stock valued at $10,568,000 after buying an additional 8,316 shares in the last quarter. Finally, Raymond James Financial Services Advisors Inc. lifted its stake in National Health Investors by 14.4% during the fourth quarter. Raymond James Financial Services Advisors Inc. now owns 30,971 shares of the real estate investment trust’s stock valued at $1,730,000 after buying an additional 3,907 shares in the last quarter. 62.51% of the stock is owned by institutional investors and hedge funds.

About National Health Investors

Incorporated in 1991, National Health Investors, Inc (NYSE:NHI) is a real estate investment trust specializing in sale, leasebacks, joint-ventures, senior housing operating partnerships, and mortgage and mezzanine financing of need-driven and discretionary senior housing and medical investments. NHI's portfolio consists of independent living, assisted living and memory care communities, entrance-fee retirement communities, skilled nursing facilities, and specialty hospitals.